top of page
Search
Writer's picturesiddhesh kapshikar
Oct 31, 20234 min read

Granulocyte Macrophage Colony Stimulating Factor Market, Global Outlook and Forecast 2023-2030

The global Granulocyte Macrophage Colony Stimulating Factor market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.


This report aims to provide a comprehensive presentation of the global market for Granulocyte Macrophage Colony Stimulating Factor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Granulocyte Macrophage Colony Stimulating Factor. This report contains market size and forecasts of Granulocyte Macrophage Colony Stimulating Factor in global, including the following market information:


Global Granulocyte Macrophage Colony Stimulating Factor Market Revenue, 2018-2023, 2024-2032, ($ millions)


Global Granulocyte Macrophage Colony Stimulating Factor Market Sales, 2018-2023, 2024-2032, (K Pcs)

Global top five Granulocyte Macrophage Colony Stimulating Factor companies in 2022 (%)


The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.

CG-0070 Segment to Reach $ Million by 2029, with a % CAGR in next six years.

The global key manufacturers of Granulocyte Macrophage Colony Stimulating Factor include Aduro BioTech Inc, Amgen Inc, BriaCell Therapeutics Corp, Cold Genesys Inc, GlaxoSmithKline Plc, Humanigen Inc, Mologen AG, Morphotek Inc and Sillajen Biotherapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.

We surveyed the Granulocyte Macrophage Colony Stimulating Factor manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Granulocyte Macrophage Colony Stimulating Factor Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)

Global Granulocyte Macrophage Colony Stimulating Factor Market Segment Percentages, by Type, 2022 (%)


  • CG-0070

  • Gimsilumab

  • GSK-3196165

  • Lenzilumab

  • MGN-1601

  • Others


Global Granulocyte Macrophage Colony Stimulating Factor Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)

Global Granulocyte Macrophage Colony Stimulating Factor Market Segment Percentages, by Application, 2022 (%)


  • Solid Tumor

  • Lymphoma

  • Kidney Cancer

  • Lung Disease

  • Others


Global Granulocyte Macrophage Colony Stimulating Factor Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)

Global Granulocyte Macrophage Colony Stimulating Factor Market Segment Percentages, By Region and Country, 2022 (%)


  • North America

  • US

  • Canada

  • Mexico

  • Europe

  • Germany

  • France

  • U.K.

  • Italy

  • Russia

  • Nordic Countries

  • Benelux

  • Rest of Europe

  • Asia

  • China

  • Japan

  • South Korea

  • Southeast Asia

  • India

  • Rest of Asia

  • South America

  • Brazil

  • Argentina

  • Rest of South America

  • Middle East & Africa

  • Turkey

  • Israel

  • Saudi Arabia

  • UAE

  • Rest of Middle East & Africa


Competitor Analysis

The report also provides analysis of leading market participants including:


  • Key companies Granulocyte Macrophage Colony Stimulating Factor revenues in global market, 2018-2023 (Estimated), ($ millions)

  • Key companies Granulocyte Macrophage Colony Stimulating Factor revenues share in global market, 2022 (%)

  • Key companies Granulocyte Macrophage Colony Stimulating Factor sales in global market, 2018-2023 (Estimated), (K Pcs)

  • Key companies Granulocyte Macrophage Colony Stimulating Factor sales share in global market, 2022 (%)


Further, the report presents profiles of competitors in the market, key players include:


  • Aduro BioTech Inc

  • Amgen Inc

  • BriaCell Therapeutics Corp

  • Cold Genesys Inc

  • GlaxoSmithKline Plc

  • Humanigen Inc

  • Mologen AG

  • Morphotek Inc

  • Sillajen Biotherapeutics

  • Takeda Pharmaceutical Co Ltd


Outline of Major Chapters:

Chapter 1: Introduces the definition of Granulocyte Macrophage Colony Stimulating Factor, market overview.

Chapter 2: Global Granulocyte Macrophage Colony Stimulating Factor market size in revenue and volume.

Chapter 3: Detailed analysis of Granulocyte Macrophage Colony Stimulating Factor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Granulocyte Macrophage Colony Stimulating Factor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Global Granulocyte Macrophage Colony Stimulating Factor capacity by region & country.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 11: The main points and conclusions of the report.

Table of content

1 Introduction to Research & Analysis Reports 1.1 Granulocyte Macrophage Colony Stimulating Factor Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Granulocyte Macrophage Colony Stimulating Factor Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global Granulocyte Macrophage Colony Stimulating Factor Overall Market Size 2.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size: 2022 VS 2030 2.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue, Prospects & Forecasts: 2018-2030 2.3 Global Granulocyte Macrophage Colony Stimulating Factor Sales: 2018-2030 3 Company Landscape 3.1 Top Granulocyte Macrophage Colony Stimulating Factor Players in Global Market 3.2 Top Global Granulocyte Macrophage Colony Stimulating Factor Companies Ranked by Revenue 3.3 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Companies 3.4 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Companies 3.5 Global Granulocyte Macrophage Colony Stimulating Factor Price by Manufacturer (2018-2023) 3.6 Top 3 and Top 5 Granulocyte Macrophage Colony Stimulating Factor Companies in Global Market, by Revenue in 2022 3.7 Global Manufact

0 views0 comments

Recent Posts

See All

Comments

bottom of page